PACIRA BIOSCIENCES INC (PCRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PCRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PCRX | Chief Executive Officer, Pacira BioSciences, Inc.; Chief Executive Officer and Director | 57 | ["Nearly three decades of global experience", "Strong track record of product development and commercial success", "Focus on patient outcomes", "Driving revenue growth and success in scaling blockbuster therapies", "Transformed organization from an early-stage drug discovery company into a clinical development company", "Global development and commercialization strategy", "U.S. P&L responsibility for major pharmaceutical products", "Responsible for setting the strategic direction of the Company", "Day-to-day leadership and management of the Company", "Provides input to the independent chair of the board for board meetings and other matters", "Facilitates communication between management and the board", "Nearly three decades of global experience in product development and commercial success", "Transformed Forma Therapeutics into a company focused on clinical development", "Responsible for driving global development and commercialization strategy at Genentech", "Formerly responsible for U.S. P&L for Herceptin\u00ae, Perjeta\u00ae, and Kadcyla\u00ae"] | ["Audit"] | 2025 |
Biography sourced from the proxy statement filing.
CHIEF EXECUTIVE OFFICER AND DIRECTOR since January 2024. As Chief Executive Officer, Mr. Lee is responsible for setting the strategic direction of the Company and for the day-to-day leadership and management of the Company. Provides input to the independent chair of the board for board meetings and other matters.